DSpace logo

Browsing by Author Murugesan, Sankaranarayanan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 10 to 29 of 59 < previous   next >
Issue DateTitleAuthor(s)
2023Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against Mycobacterium tuberculosisMurugesan, Sankaranarayanan
2022-06Design, synthesis and evaluation of novel phenanthridine triazole analogs as potential antileishmanial agentsMurugesan, Sankaranarayanan
2021-09Design, synthesis and evaluation of novel β-carboline ester analogues as potential anti-leishmanial agentsMurugesan, Sankaranarayanan
2022-01Design, synthesis and structure–activity relationship studies of novel spirochromanone hydrochloride analogs as anticancer agentsMurugesan, Sankaranarayanan
2023-01Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybridsMurugesan, Sankaranarayanan
2020-07Design, synthesis, in silico studies, and evaluation of novel chalcones and their pyrazoline derivatives for antibacterial and antitubercular activitiesMurugesan, Sankaranarayanan
2020-05Design, synthesis, α-amylase inhibition and in silico docking study of novel quinoline bearing proline derivativesMurugesan, Sankaranarayanan
2020-07Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agentsMurugesan, Sankaranarayanan
2023-07Discovery of Novel Coumarin-Schiff Base Hybrids as Potential Acetylcholinesterase Inhibitors: Design, Synthesis, Enzyme Inhibition, and Computational StudiesMurugesan, Sankaranarayanan
2023-04Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approachesMurugesan, Sankaranarayanan
2020-11Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19Murugesan, Sankaranarayanan
2020-02Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapyMurugesan, Sankaranarayanan
2023-04Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug CandidatesMurugesan, Sankaranarayanan
2022Graph theoretical network analysis, in silico exploration, and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against α-synucleinMurugesan, Sankaranarayanan
2019Green Synthesis, in-vitro Antimicrobial Evaluation, Docking, and SAR Studies of Potent Quinoline-4-Carboxylic AcidsJha, Prabhat N.; Murugesan, Sankaranarayanan; Shukla, Paritosh
2022-12Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approachMurugesan, Sankaranarayanan
2022-08In silico and in vitro analysis of PPAR – α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistatMurugesan, Sankaranarayanan
2023-07In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation – Targeting Mpro and pan-coronavirus post-fusion Spike proteinMurugesan, Sankaranarayanan
2023-11In Silico Exploration of Bisphosphonate Scaffolds as Potential Inhibitors of SARS-CoV-2 RdRp for COVID-19 and PASCMurugesan, Sankaranarayanan
2020-10In-vivo and in-silico toxicity studies of daidzein: an isoflavone from soyMurugesan, Sankaranarayanan